BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16574217)

  • 21. Drug-polymer microparticles produced by supercritical assisted atomization.
    Reverchon E; Antonacci A
    Biotechnol Bioeng; 2007 Aug; 97(6):1626-37. PubMed ID: 17286274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphiphilic comb-like polymers based on poly(oxyethylene)s as drug-delivery carriers.
    Kim KH; Lee JC; Lee J
    Macromol Biosci; 2008 Apr; 8(4):339-46. PubMed ID: 18098266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen-bonded interpolymer complexes as materials for pharmaceutical applications.
    Khutoryanskiy VV
    Int J Pharm; 2007 Apr; 334(1-2):15-26. PubMed ID: 17320317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research on intelligent controlled drug delivery with polymer].
    Zhang Z; Tang C; Chen H; Shan L; Wan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):205-8, 224. PubMed ID: 16532842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymer blends for controlled release coatings.
    Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system.
    Lee WL; Widjaja E; Loo SC
    Small; 2010 May; 6(9):1003-11. PubMed ID: 20358528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucoadhesive polymeric platforms for controlled drug delivery.
    Andrews GP; Laverty TP; Jones DS
    Eur J Pharm Biopharm; 2009 Mar; 71(3):505-18. PubMed ID: 18984051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrohydrodynamic atomization for biodegradable polymeric particle production.
    Xie J; Lim LK; Phua Y; Hua J; Wang CH
    J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic synthesis of advanced microparticles for encapsulation and controlled release.
    Duncanson WJ; Lin T; Abate AR; Seiffert S; Shah RK; Weitz DA
    Lab Chip; 2012 Jun; 12(12):2135-45. PubMed ID: 22510961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?
    Tran VT; Benoît JP; Venier-Julienne MC
    Int J Pharm; 2011 Apr; 407(1-2):1-11. PubMed ID: 21256947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.
    Wang Y; Chang HI; Wertheim DF; Jones AS; Jackson C; Coombes AG
    Biomaterials; 2007 Nov; 28(31):4619-27. PubMed ID: 17659772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow Focusing: a versatile technology to produce size-controlled and specific-morphology microparticles.
    Martín-Banderas L; Flores-Mosquera M; Riesco-Chueca P; Rodríguez-Gil A; Cebolla A; Chávez S; Gañán-Calvo AM
    Small; 2005 Jul; 1(7):688-92. PubMed ID: 17193506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to prepare microparticles of uniform size.
    Muramatsu N; Kondo T
    J Microencapsul; 1995; 12(2):129-36. PubMed ID: 7629655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-dimensional (3D) fabricated polymer based drug delivery systems.
    Moulton SE; Wallace GG
    J Control Release; 2014 Nov; 193():27-34. PubMed ID: 25020039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.